quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:27:45·1697d
INSIDERFiling
U S Concrete, Inc. logo

SEC Form 4: Penkar Rajan returned $416,620 worth of Common stock to the company (5,630 units at $74.00), closing all direct ownership in the company

USCR· U S Concrete, Inc.
Capital Goods
Original source

Companies

  • USCR
    U S Concrete, Inc.
    Capital Goods

Related

  • SEC1689d
    SEC Form 15-12B filed by U S Concrete, Inc.
  • INSIDER1697d
    SEC Form 4: Sutherland Colin Mcgill returned $1,084,766 worth of Common stock to the company (14,659 units at $74.00), closing all direct ownership in the company
  • INSIDER1697d
    SEC Form 4: Rossi Theodore P returned $6,855,064 worth of Common stock to the company (92,636 units at $74.00), closing all direct ownership in the company
  • INSIDER1697d
    SEC Form 4: Roberts Jeffrey W returned $1,862,580 worth of Common stock to the company (25,170 units at $74.00), closing all direct ownership in the company to cover withholding tax
  • INSIDER1697d
    SEC Form 4: Peabody Mark Baker returned $3,051,908 worth of Common stock to the company (41,242 units at $74.00), closing all direct ownership in the company to cover withholding tax
  • INSIDER1697d
    SEC Form 4: Lundin Michael D returned $5,805,078 worth of Common stock to the company (78,447 units at $74.00), closing all direct ownership in the company
  • INSIDER1697d
    SEC Form 4: Lesley Philip Daren returned $1,152,106 worth of Common stock to the company (15,569 units at $74.00), closing all direct ownership in the company to satisfy withholding tax
  • INSIDER1697d
    SEC Form 4: Kunz John E gifted 1,351 units of Common stock and returned $2,756,796 worth of Common stock to the company (37,254 units at $74.00), closing all direct ownership in the company (for tax liability)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022